Trial data indicate that the efficacy of Porcilis M Hyo is not affected by the presence of maternal antibodies at the time of vaccination.
Porcilis M Hyo
Solid protection against M. hyopneumoniae infections
Both laboratory trials and field trials demonstrate solid protection against
M. hyopneumoniae infections when using Porcilis M Hyo.
Rapid onset of immunity and significant protection up until slaughter
Onset of immunity - From 2 weeks after second vaccination.
Duration of immunity -protection proven for at least 20 weeks after second dose.
Porcilis M Hyo protects profits
Significant reduction in pulmonary lesions due to M. hyopneumoniae infection and consistently
improved weight gain during the fattening period is seen even on farms with a low M. hyopneumoniae
challenge.
No interference by MDA
Trial data indicate that the efficacy of Porcilis M Hyo is not affected by the presence of
maternal antibodies at the time of vaccination:
- All field trials involving the vaccination of MDA+ pigs resulted in a significant reduction in lung lesions and a consistently improved weight gain during the fattening period.
- Results of vaccination/challenge studies were the same irresepective of the presence of MDA.
- There is no correlation between MDA levels at vaccination and the efficacy of Porcilis M Hyo.
More information:
- Porcilis M Hyo description
- Porcilis M Hyo product brochure:
